General Catalyst’s HATCo to buy Summa Health for $485M
General Catalyst’s HATCo has also committed $350 million for the first five years of the deal.
Related Articles
Recurrence in Young Patients With ER-Positive, ERBB2-Negative Breast Cancer
This cohort study examines the association of age with late distant recurrence in patients aged 45 years or younger with estrogen receptor (ER)–positive, ERBB2-negative breast…
Drone market growth driven by service applications rather than hardware
With heightened US-China tech competition looming ahead of the US presidential election, one outcome seems certain: the rivalry—especially in drones—will only accelerate efforts to reduce…
Change of Ownership and Quality of Home Health Agency Care
This difference-in-differences analysis investigates changes in ownership of home health agencies in the US and associated changes in quality of care, patient volume, and staffing…
Mitochondrial dynamics provide clues for halting the metastatic progression of breast cancer
Mitochondria have long been known as the tiny organelles that act as the battery packs inside our cells while also serving as internal sensors and…
Diane Shao – 2023 STAT Wunderkinds
Using genetics to probe the origins of neurodevelopmental disabilities Ahmed Ahmed blends public policy with medicine to learn about the healthcare workforce. Read his story.
Researchers are one step closer to developing cell-based therapy for hypothyroidism
Researchers from the Center for Regenerative Medicine (CReM) and the Department of Medicine at Boston Medical Center (BMC) and Boston University (BU) have made a…
Cracking the code of DNA circles in cancer, Stanford Medicine-led team uncovers potential therapy
Tiny circles called ecDNA are critical in cancer development and drug resistance. An international Stanford Medicine-led team publishes landmark studies detailing new findings and potential…
Salivary Enzyme Behind Our Carb Cravings May Have Unexpectedly Ancient History
Digestion involves much more than just your stomach. The digestive process that fuels your body begins in your mouth each time you take a bite…
The rapid rise of the UK’s cancer vaccine trials
The UK is making progress in developing cancer vaccines, but there are still challenges ahead, Chris Baraniuk reports The UK is on its way to…
